Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...

Pfizer is launching the first clinical trials for its PD-1xVEGF drug, while Akeso detailed the first overall survival win for ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, will ...

Eli Lilly stock soars on obesity drug success. See here to know why LLY remains a top pick with strong growth prospects and a ...

Chris Rock told “SNL” boss Lorne Michaels to quit after Eddie Murphy-hosted episode ...

Toni Braxton's 'He Wasn't Man Enough' has new life as Lifetime movie ...

Gen. Shaw sends troops into the sewage tunnels under Derry. The children send themselves there, too. Bad idea in both cases.

But these eye-popping innovations have an effect only if they can make their way to the patients who need them. That reality ...

The phase 2 ChonDRAgon study compared ozekibart to placebo in patients with metastatic or unresectable conventional chondrosarcoma who been diagnosed with radiographic progression.

As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (GAAP) are increasingly recognized as meaningful signals of ...

IT: Welcome to Derry Episode 5, "29 Neibolt Street" delivers on its promise of a tense and action-packed episode. The army ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...